Get all your news in one place.
100's of premium titles.
One app.
Start reading
Evening Standard
Evening Standard
Business
Michael Hunter

GSK unveils £1.6 billion deal to buy Canadian medicine maker Bellus Health and its blockbuster cough drug

GSK announced plans today to spend £1.6 billion on buying Canadian drug maker Bellus Health in a move that will help revitalise the City’s reputation for dealmaking while bringing a potential blockbuster cough treatment to the FTSE 100 company.

The $2 billion shot in the arm for the capital comes after a recent quiet spell for mergers and acquisitions added to worries about its status as a major international M&A venue.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.